Idaho
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
No racial disparities were found in Idaho for these lung cancer metrics
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in Idaho is 43.9 and significantly lower than the national rate of 52.8.
- Idaho ranks 9th among all states, placing it in the above average tier.
- Over the last five years, the rate of new cases in Idaho improved by 16%.
- In 2022, the most recent year of data available for this report, the COVID-19 pandemic continued to disrupt access to medical care, including delays and reductions in cancer diagnoses and screening. This led to a decline in incidence rates for most cancers, including lung cancer, and should not be interpreted as a reduction in the underlying cancer burden.
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer in Idaho is 31.2%, which is not significantly different than the national rate of 29.7%.
- It ranks 13th among the 39 states with survival data, placing it in the average tier.
- Over the last five years, the survival rate in Idaho improved by 38%.
Early Diagnosis:
- In Idaho, 28.8% of cases are caught at an early stage, which is not significantly different than the national rate of 28.1%.
- It ranks 22nd among the 50 states with data on diagnosis at an early stage, placing it in the average tier.
- Over the last five years, the early diagnosis rate in Idaho did not change significantly.
Lung Cancer Treatment
- Idaho has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of August 2025.
Surgical Treatment:
- Idaho ranked 31st (out of the 49 states with available data) with 18.2% of cases undergoing surgery as part of the first course of treatment.
- This is significantly lower than the national rate of 20.7% and puts Idaho in the below average tier.
- Over the last five years, the percent of cases undergoing surgery in Idaho did not change significantly.
No Treatment:
- Idaho ranked 42nd (out of the 49 states with available data) with 24.5% of cases not receiving any treatment.
- This is significantly higher than the national rate of 21.0% and puts Idaho in the below average tier.
- Over the last five years, the percent of cases receiving no treatment in Idaho did not change significantly.
Screening
Screening for High Risk:
- In Idaho, 16.3% of those at high risk were screened, which was not significantly different than the national rate of 18.2%.
- It ranks 34th among all states, placing it in the below average tier.
Prevention
Tobacco Use:
- The 2023 smoking rate in Idaho is 10.4% and not significantly different than the national rate of 11.4%.
- It ranks 14th among all states, placing it in the average tier.
Radon:
- In Idaho, 33.3% of radon test results were at or above the action level recommended by EPA.
- It ranks 33rd among all states, placing it in the below average tier.
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 59.6 per 100,000 population among Black individuals in Idaho, not significantly different than the rate of 54.2 among Black individuals nationally, and not significantly different than the rate of 44.5 among white individuals in Idaho.
- Survival rates by race and ethnicity are not available for Idaho at this time. Nationally, the five-year survival rate among Black individuals is 27.1%, 9% lower than among white Americans.
- Other lung cancer rates are not available for Black individuals in Idaho due to too few cases over the time period to allow for accurate analysis.
Latino individuals:
- The rate of new lung cancer cases is 32.4 per 100,000 population among Latino individuals in Idaho, not significantly different than the rate of 27.9 among Latino individuals nationally, and significantly lower than the rate of 44.5 among white individuals in Idaho.
- State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
- 23.9% of lung cancer cases are diagnosed at an early stage among Latino individuals in Idaho, not significantly different than the rate of 23.9% among Latino individuals nationally, and not significantly different than the rate of 28.9% among white individuals in Idaho.
- 17.2% of Latino individuals with lung cancer in Idaho underwent surgery, not significantly different than the rate of 21.4% among Latino individuals nationally, and not significantly different than the rate of 18.1% among white individuals in Idaho.
- 21.9% of Latino individuals with lung cancer in Idaho did not receive any treatment, not significantly different than the rate of 25.8% among Latino individuals nationally, and not significantly different than the rate of 24.6% among white individuals in Idaho.
Asian Americans or Pacific Islanders:
- The rate of new lung cancer cases is 37.2 per 100,000 population among Asian or Pacific Islanders individuals in Idaho, not significantly different than the rate of 32.5 among Asian or Pacific Islanders individuals nationally, and not significantly different than the rate of 44.5 among white individuals in Idaho.
- State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
- 24.1% of lung cancer cases are diagnosed at an early stage among Asian or Pacific Islander individuals in Idaho, not significantly different than the rate of 23.7% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 28.9% among white individuals in Idaho.
- Other lung cancer rates are not available for Asian or Pacific Islander individuals in Idaho due to too few cases over the time period to allow for accurate analysis.
Indigenous Peoples:
- The rate of new lung cancer cases is 42.3 per 100,000 population among Indigenous peoples (American Indians/Alaska Natives) in Idaho, not significantly different than the rate of 39.8 among Indigenous Peoples nationally, and not significantly different than the rate of 44.5 among white individuals in Idaho.
- State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
- Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in Idaho due to too few cases over the time period to allow for accurate analysis.
Summary
Despite the early diagnosis rate in Idaho falling into the average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
Idaho has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
It is alarming that Idaho falls into the below average tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: October 1, 2025